See more : PacWest Bancorp (PACW) Income Statement Analysis – Financial Results
Complete financial analysis of Diamyd Medical AB (publ) (DMYD-B.ST) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Diamyd Medical AB (publ), a leading company in the Biotechnology industry within the Healthcare sector.
- Branicks Group AG (DDCCF) Income Statement Analysis – Financial Results
- Sungold Capital Limited (SUNGOLD.BO) Income Statement Analysis – Financial Results
- Western Acquisition Ventures Corp. (WAVSU) Income Statement Analysis – Financial Results
- United Recommend International Co., Ltd. (5321.TWO) Income Statement Analysis – Financial Results
- Shanghai Xintonglian Packaging Co., Ltd. (603022.SS) Income Statement Analysis – Financial Results
Diamyd Medical AB (publ) (DMYD-B.ST)
About Diamyd Medical AB (publ)
Diamyd Medical AB (publ) develops therapies for the treatment of autoimmune diabetes. The company develops Diamyd, an antigen-specific immunotherapy diabetes vaccine, which is in phase IIb clinical trial for the treatment of type 1 diabetes and latent autoimmune diabetes; and Remygen, an oral regenerative and immunomodulatory drug candidate, which is in phase I/II clinical trial for the treatment of autoimmune and type 2 diabetes. The company was formerly known as Diamyd Therapeutics AB and changed its name to Diamyd Medical AB (publ) in April 2013. Diamyd Medical AB (publ) was incorporated in 1984 and is based in Stockholm, Sweden.
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 130.00K | 546.00K | 454.00K | 253.00K | 341.00K | 1.57M | 726.00K | 922.00K | 757.00K | 513.00K | 443.00K | 100.00K | 1.08M | 280.75M | 113.03M |
| Cost of Revenue | 3.71M | 3.63M | 4.40M | 2.50M | 4.49M | 1.69M | 2.11M | 1.74M | 911.00K | 1.35M | 1.26M | 756.00K | 0.00 | 7.00K | 26.00K |
| Gross Profit | -3.58M | -3.09M | -3.95M | -2.25M | -4.15M | -125.00K | -1.38M | -818.00K | -154.00K | -838.00K | -819.00K | -656.00K | 1.08M | 280.75M | 113.00M |
| Gross Profit Ratio | -2,753.85% | -565.57% | -869.82% | -888.54% | -1,216.13% | -7.97% | -190.50% | -88.72% | -20.34% | -163.35% | -184.88% | -656.00% | 100.00% | 100.00% | 99.98% |
| Research & Development | 96.48M | 69.91M | 75.57M | 56.86M | 13.81M | 22.36M | 29.12M | 12.87M | 6.22M | 9.69M | 5.47M | 3.52M | 25.05M | 95.98M | 80.85M |
| General & Administrative | 0.00 | 0.00 | 11.67M | 9.46M | 6.86M | 6.02M | 5.41M | 4.66M | 4.51M | 4.11M | 3.61M | 3.43M | 12.71M | 15.76M | 19.10M |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 44.79M | 39.70M | 11.67M | 9.46M | 6.86M | 6.02M | 5.41M | 4.66M | 4.51M | 4.11M | 3.61M | 3.43M | 12.71M | 15.76M | 19.10M |
| Other Expenses | 1.72M | 42.85M | 23.75M | 17.32M | -34.56M | 8.07M | 8.13M | 7.17M | 21.17M | 6.94M | 6.83M | 5.42M | 26.75M | 410.00K | 410.00K |
| Operating Expenses | 142.99M | 112.76M | 110.99M | 83.63M | -13.89M | 36.44M | 42.65M | 24.70M | 31.91M | 20.73M | 15.91M | 12.38M | 64.50M | 169.41M | 115.97M |
| Cost & Expenses | 146.70M | 116.39M | 115.39M | 86.13M | -9.40M | 38.14M | 44.76M | 26.44M | 32.82M | 22.08M | 17.18M | 13.13M | 64.50M | 169.41M | 115.99M |
| Interest Income | 6.00M | 4.74M | 8.26M | 1.97M | 500.00K | 80.00K | 285.00K | 32.00K | 51.00K | 0.00 | 0.00 | 399.00K | 514.00K | 0.00 | 0.00 |
| Interest Expense | 2.14M | 3.00K | 253.00K | 453.00K | 530.00K | 121.00K | 202.00K | 67.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 10.99M | 4.87M | 4.38M | 782.00K | 149.00K | 140.00K | 131.00K | 106.00K | 106.00K | 26.00K | 108.00K | 155.00K | 17.14M | 428.00K | 224.00K |
| EBITDA | -141.69M | -110.98M | -95.90M | -85.29M | -33.28M | -36.35M | -43.82M | -25.42M | -31.90M | -21.54M | -16.62M | -12.88M | -16.11M | 111.77M | -2.74M |
| EBITDA Ratio | -108,995.38% | -20,366.67% | -23,245.15% | -32,858.89% | 3,046.33% | -2,318.18% | -6,008.26% | -2,752.93% | -2,431.97% | -4,199.22% | -3,752.60% | -12,877.00% | -4,293.51% | 39.81% | -2.42% |
| Operating Income | -146.57M | -120.81M | -118.18M | -85.88M | 9.74M | -36.57M | -44.04M | -25.52M | -32.06M | -21.57M | -16.73M | -13.03M | -63.43M | 111.34M | -2.96M |
| Operating Income Ratio | -112,743.85% | -22,125.64% | -26,029.96% | -33,944.66% | 2,856.01% | -2,332.21% | -6,065.56% | -2,767.90% | -4,235.01% | -4,204.29% | -3,776.98% | -13,032.00% | -5,883.58% | 39.66% | -2.62% |
| Total Other Income/Expenses | -5.28M | 9.69M | 14.66M | 145.93M | -30.00K | -41.00K | 83.00K | -35.00K | 51.00K | 171.00K | 698.00K | 399.00K | 514.00K | -9.50M | 2.69M |
| Income Before Tax | -151.85M | -116.07M | -103.52M | 60.05M | 9.71M | -36.61M | -43.95M | -25.56M | -32.01M | -21.40M | -16.03M | -12.63M | -51.52M | 101.84M | -276.00K |
| Income Before Tax Ratio | -116,807.69% | -21,258.97% | -22,800.88% | 23,733.60% | 2,847.21% | -2,334.82% | -6,054.13% | -2,771.69% | -4,228.27% | -4,170.96% | -3,619.41% | -12,633.00% | -4,778.76% | 36.28% | -0.24% |
| Income Tax Expense | 0.00 | 4.73M | -14.66M | -143.96M | 530.00K | 121.00K | 286.00K | 33.00K | 13.54M | 0.00 | 0.00 | 0.00 | 160.00K | -727.00K | 56.00K |
| Net Income | -151.85M | -116.07M | -88.86M | 204.01M | 9.71M | -36.73M | -43.95M | -25.56M | -32.01M | -21.40M | -16.03M | -12.63M | -51.68M | 102.57M | -332.00K |
| Net Income Ratio | -116,807.69% | -21,258.79% | -19,572.03% | 80,635.18% | 2,847.21% | -2,342.54% | -6,054.13% | -2,771.69% | -4,228.27% | -4,170.96% | -3,619.41% | -12,633.00% | -4,793.60% | 36.53% | -0.29% |
| EPS | -1.60 | -1.48 | -1.13 | 2.78 | 0.14 | -0.55 | -0.78 | -0.74 | -1.10 | -0.80 | -0.63 | -0.78 | -3.59 | 2.50 | -0.01 |
| EPS Diluted | -1.60 | -1.48 | -1.13 | 2.78 | 0.14 | -0.55 | -0.76 | -0.72 | -1.10 | -0.80 | -0.63 | -0.78 | -3.59 | 2.50 | -0.01 |
| Weighted Avg Shares Out | 94.71M | 78.29M | 78.38M | 73.30M | 70.85M | 66.96M | 56.33M | 34.60M | 29.03M | 26.61M | 25.59M | 16.26M | 14.39M | 41.15M | 38.56M |
| Weighted Avg Shares Out (Dil) | 94.71M | 78.29M | 78.38M | 73.30M | 70.85M | 66.96M | 57.70M | 35.63M | 29.03M | 26.61M | 25.59M | 16.26M | 14.39M | 41.19M | 38.56M |
Source: https://incomestatements.info
Category: Stock Reports